Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pharmacol Exp Ther ; 323(1): 61-9, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17626795

RESUMO

To be able to address the question how neurotransmitters or pharmacological agents influence activity of neuronal populations in freely moving animals, the combidrive was developed. The combidrive combines an array of 12 tetrodes to perform ensemble recordings with a moveable and replaceable microdialysis probe to locally administer pharmacological agents. In this study, the effects of cumulative concentrations of tetrodotoxin, lidocaine, and muscimol on neuronal firing activity in the prefrontal cortex were examined and compared. These drugs are widely used in behavioral studies to transiently inactivate brain areas, but little is known about their effects on ensemble activity and the possible differences between them. The results show that the combidrive allows ensemble recordings simultaneously with reverse microdialysis in freely moving rats for periods at least up to 2 wk. All drugs reduced neuronal firing in a concentration dependent manner, but they differed in the extent to which firing activity of the population was decreased and the in speed and extent of recovery. At the highest concentration used, both muscimol and tetrodotoxin (TTX) caused an almost complete reduction of firing activity. Lidocaine showed the fastest recovery, but it resulted in a smaller reduction of firing activity of the population. From these results, it can be concluded that whenever during a behavioral experiment a longer lasting, reversible inactivation is required, muscimol is the drug of choice, because it inactivates neurons to a similar degree as TTX, but it does not, in contrast to TTX, affect fibers of passage. For a short-lasting but partial inactivation, lidocaine would be most suitable.


Assuntos
Lidocaína , Microdiálise/métodos , Muscimol , Neurônios/fisiologia , Tetrodotoxina , Potenciais de Ação/efeitos dos fármacos , Animais , Relação Dose-Resposta a Droga , Lidocaína/administração & dosagem , Lidocaína/farmacologia , Masculino , Microdiálise/instrumentação , Modelos Animais , Muscimol/administração & dosagem , Muscimol/farmacologia , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Neurotransmissores/metabolismo , Neurotransmissores/fisiologia , Ratos , Ratos Wistar , Tetrodotoxina/administração & dosagem , Tetrodotoxina/farmacologia
2.
J Vet Pharmacol Ther ; 26(3): 165-71, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12755899

RESUMO

The aims of this investigation were to calculate the pharmacokinetic parameters and to identify parameters, based on individual plasma concentration-time curves of amoxicillin and clavulanic acid in dogs, that may govern the observed differences in absorption of both drugs. The evaluation was based on the data from plasma concentration-time curves obtained following a single dose in an open, randomized, two-way crossover study involving 24 male Beagle dogs treated with two Amoxi-Clav formulations (A Clavubactin and B Synulox, each with 200/50 mg). Plasma amoxicillin and clavulanic acid concentrations were determined using validated bioassay methods. The half-life of elimination of amoxicillin was 1.5 h (t1/2 = 1.52 +/- 0.19 h, Cmax = 11.4 +/- 2.74 microg/mL), and that of clavulanic acid 0.76 h (t1/2 = 0.71 +/- 0.23 h, Cmax = 2.06 +/- 1.05 microg/mL). There was a fivefold variation in the AUCt of clavulanic acid for both formulations, while the AUCt of amoxicillin varied by a factor of 2. The mean ratio of the AUCt amoxicillin : clavulanic acid was 12.7 +/- 3.65 for formulation A and 11.8 +/- 5.22 for formulation B (P = 0.51).


Assuntos
Combinação Amoxicilina e Clavulanato de Potássio/farmacocinética , Cães/metabolismo , Quimioterapia Combinada/farmacocinética , Administração Oral , Amoxicilina/administração & dosagem , Amoxicilina/sangue , Amoxicilina/farmacocinética , Combinação Amoxicilina e Clavulanato de Potássio/administração & dosagem , Combinação Amoxicilina e Clavulanato de Potássio/sangue , Animais , Área Sob a Curva , Ácido Clavulânico/administração & dosagem , Ácido Clavulânico/sangue , Ácido Clavulânico/farmacocinética , Estudos Cross-Over , Combinação de Medicamentos , Quimioterapia Combinada/administração & dosagem , Quimioterapia Combinada/sangue , Masculino , Valores de Referência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...